Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
ID: 356043Type: Forecasted
Overview

Buyer

Food and Drug Administration (HHS-FDA)

Award Range

$11M - $11M

Eligible Applicants

Others

Funding Category

Consumer Protection

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives." This cooperative agreement aims to enhance the capabilities of State animal food regulatory programs to fully implement the Animal Feed Regulatory Program Standards (AFRPS) and to foster mutual reliance between federal and state regulatory efforts. The initiative is critical for establishing a nationally integrated animal food safety system, ensuring that state programs can effectively standardize processes and procedures in collaboration with federal resources. Interested organizations can apply for funding amounts set at $10,600,000, with an expected 30 awards available for fiscal year 2025. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Animal Food Regulatory Program Alliance
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Animal Food Regulatory Program Alliance," aimed at enhancing the national food safety system through improved collaboration among federal and state agencies. The primary objective of this program is to support the development of a national integrated animal food safety system, which includes sharing best practices, conducting training programs, and advancing the Animal Food Regulatory Program Standards (AFRPS). This initiative is crucial for ensuring public health and consumer protection in the regulation of manufactured foods. Interested national associations or organizations that represent state animal food regulatory programs can apply for funding, with a total award amount of $600,000. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610. The fiscal year for this opportunity is 2025.
    Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F)," aimed at enhancing state manufactured food regulatory programs. This cooperative agreement seeks to support the development and maintenance of Manufactured Food Regulatory Program Standards (MFRPS) to ensure high-quality regulatory frameworks that improve food safety and reduce foodborne illness hazards. Eligible applicants include state, tribal, and territorial food safety programs with existing FDA food safety inspection contracts or those willing to enter into such contracts, with funding amounts ranging from $340,000 to $1,285,000 per year. Interested parties can contact Terrin Brown at terrin.brown@fda.hhs.gov or (240) 402-7610 for further information, with applications expected to align with the fiscal year 2024 timeline.
    Manufactured Foods Flexible Funding Model (MF-FFM)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "Manufactured Foods Flexible Funding Model (MF-FFM)" aimed at advancing a nationally integrated food safety system. This cooperative agreement seeks to support initiatives related to Manufactured Food Regulatory Program Standards (MFRPS), dietary supplement safety, and state compliance and enforcement infrastructure, with a focus on enhancing food safety practices across jurisdictions. The program is critical for ensuring that state regulatory programs maintain high-quality standards and best practices in food safety. Interested applicants, which include state, local, territorial, and tribal agencies, as well as non-profit training entities collaborating with higher education institutions, can reach out to Gordana Zuber at gordana.zuber@fda.hhs.gov or by phone at 301-348-1747 for further details. The estimated project start date is July 1, 2023, with approximately 50 awards expected under this discretionary funding opportunity.
    Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a grant opportunity titled "Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed." This initiative aims to establish and sustain Rapid Response Teams (RRTs) to enhance the national integrated food safety system by coordinating federal, state, and local emergency response efforts related to human and animal food safety. The program is critical for improving regulatory and surveillance capabilities, ensuring rapid identification and removal of contaminated food, and fostering continuous improvement in response strategies. Interested applicants, including state governments and other entities, can apply for funding ranging from $360,000 to $1,440,000, with an expected four awards to be made. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610.
    Retail Food Safety Regulatory Association Collaboration CAP
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Retail Food Safety Regulatory Association Collaboration CAP," aimed at enhancing retail food safety initiatives across the United States. This opportunity is specifically designed for non-profit national organizations affiliated with higher education institutions, whose members include regulatory personnel focused on retail food safety, as permitted by the Food Safety Modernization Act (FSMA). The initiative seeks to reduce foodborne illness by advancing practices in retail food protection, conducting relevant research, and fostering collaboration among stakeholders. The total funding available for this opportunity is $4 million, with an expected five awards to be made, and interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610 for further details.
    Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a grant opportunity titled "Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center," aimed at establishing a National Coordination Center (NCC) for the Regulatory and Laboratory Training System (RLTS). The selected non-profit entity will oversee the administration of the RLTS, implement strategic plans, manage communications, and facilitate stakeholder engagement to enhance training resources for food safety. This initiative is crucial for improving access to high-quality regulatory and laboratory training for both human and animal food sectors. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610 for further details. The grant has a funding ceiling and floor of $1.5 million, with one award expected in fiscal year 2025.
    Rapid Response Team (RRT) Cooperative Agreement
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the Rapid Response Team (RRT) Cooperative Agreement, aimed at enhancing the national integrated food safety system. This initiative seeks to unify and coordinate emergency response efforts related to human and animal food (HAF), focusing on strengthening connections among epidemiology, laboratory, and regulatory components, as well as improving state regulatory and surveillance programs. The total estimated funding for this program is $8,250,000, with approximately 25 awards expected, and interested small businesses can reach out to Janelle Fundersburg at 301-798-2533 or via email at janelle.fundersburg@fda.hhs.gov for further details. The synopsis is anticipated to be posted on September 1, 2022, with a closing date for applications on December 1, 2022, and awards expected to be made by July 1, 2023.
    NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the NARMS Cooperative Agreement Program, aimed at strengthening antibiotic resistance surveillance in retail food specimens. This initiative seeks to enhance the National Antimicrobial Resistance Monitoring System (NARMS) by improving the detection of antibiotic resistance among bacteria in food commodities and expanding sampling efforts to new sites. The program is critical for public health as it addresses the growing threat of antibiotic resistance, ensuring better monitoring and response strategies. Interested applicants can apply for a total funding amount of up to $4.5 million, with an expected 30 awards available, and should contact Terrin Brown at terrin.brown@fda.hhs.gov or 240-402-7610 for further details.
    Minor Use Minor Species Development of Drugs (R01)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the development of drugs for minor uses in major species or for use in minor species through its Minor Use Minor Species Development of Drugs (R01) grant program. This initiative aims to support research projects that assist in the safety and effectiveness testing of new animal drugs designated for minor uses, with a focus on entities that have opened an Investigational New Animal Drug (INAD) file and received the necessary designations from the FDA's Office of Minor Use and Minor Species Animal Drug Development. The program is crucial for enhancing veterinary care options for less common animal species, ensuring that these drugs meet FDA approval standards. Interested applicants can apply for grants with a funding ceiling of $250,000, with an expected six awards available for the fiscal year 2025. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at (240) 402-7610.
    Collaborations to Enhance Drug Development and Regulatory Science
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is inviting applications for a federal grant titled "Collaborations to Enhance Drug Development and Regulatory Science." This opportunity aims to establish cooperative agreements that support Public-Private Partnerships and collaborative activities under the Critical Path Initiative, focusing on innovative projects that enhance drug product development, advanced manufacturing, and the translation of scientific discoveries into therapeutics. The initiative is crucial for fostering innovation in drug safety, efficacy, quality, and performance, with a total funding ceiling of $5 million available for six expected awards in fiscal year 2024. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or call (240) 402-7610 for further information.